NCT06734585 2025-09-12Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell TransplantAstellas Pharma IncCompleted114 enrolled
NCT04691648 2025-05-31A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) MutationAstellas Pharma IncCompleted33 enrolled